Afya (NASDAQ:AFYA) Stock Rating Lowered by UBS Group

Afya (NASDAQ:AFYA) was downgraded by analysts at UBS Group from a “buy” rating to a “neutral” rating in a report issued on Friday, Marketbeat Ratings reports. They presently have a $16.00 price target on the stock. UBS Group’s price objective points to a potential upside of 14.86% from the stock’s current price.

Several other research firms have also recently issued reports on AFYA. Sanford C. Bernstein raised Afya to a “market perform” rating in a report on Friday. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 target price (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Wall Street Zen raised Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 10th. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.38.

Afya Trading Down 3.2%

Shares of NASDAQ:AFYA opened at $13.93 on Friday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21. The company’s 50-day moving average price is $14.78 and its 200 day moving average price is $15.04. The company has a market cap of $1.31 billion, a PE ratio of 10.02, a P/E/G ratio of 0.53 and a beta of 0.53. Afya has a fifty-two week low of $13.12 and a fifty-two week high of $19.90.

Institutional Trading of Afya

Several hedge funds and other institutional investors have recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its holdings in shares of Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after buying an additional 28,226 shares during the period. Perpetual Ltd lifted its position in Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after acquiring an additional 2,730 shares during the last quarter. R Squared Ltd bought a new stake in Afya during the second quarter valued at about $264,000. Carrera Capital Advisors bought a new stake in Afya during the second quarter valued at about $1,750,000. Finally, Campbell & CO Investment Adviser LLC grew its position in shares of Afya by 31.5% in the second quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock valued at $917,000 after purchasing an additional 12,286 shares during the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.